PROK Stock: ProKidney Corp. Stock Price, Analysis & Insights
Get live prok stock price $2.48, comprehensive ProKidney Corp. stock analysis, charts, news, and expert forecast. Real-time prok stock data and investment insights.
Company Overview
ProKidney Corp., a clinical-stage biotechnology, engages in developing cellular therapy candidates. It is developing Renal Autologous Cell Therapy, an autologous homologous cell admixture that is in a Phase III development program, as well as Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease; and Phase I clinical trial for patients with congenital anomalies of the kidney and urinary tract. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.
Company Information
- CEO
- Bruce Culleton
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 204
Contact Information
- Website
- https://www.prokidney.com
- Address
- 2000 Frontis Plaza Blvd.
- Country
- US
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 741.51M market capitalization
- Trading Volume: 8.19M shares traded today
- Price Range: 52-week range of $0.46 - $7.13
- Exchange: Listed on NASDAQ Capital Market
Financial Metrics
Market Analysis for ProKidney Corp.
ProKidney Corp. (PROK) operates in the Biotechnology industry within the Healthcare sector. With a current market capitalization of 741.51M, the company represents a significant player in its market. The stock is currently trading at $2.48 with a negativedaily change of 16.78%.
The company's 204 employee base and presence on the NASDAQ Capital Marketexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -4.43, beta of 1.79, and 52-week price range from $0.46 to $7.13when evaluating investment opportunities.
Why Invest in ProKidney Corp.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Capital Market)
- • Experienced leadership under Bruce Culleton
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.